CTNM Free Cash Flow

Annual FCF

$18.93 M
+$39.17 M+193.56%

December 31, 2023

Summary

Performance

1-Year Change

+193.56%

3-Year Change

+171.63%

5-Year Change

+171.63%

15-Year Change

+171.63%

CTNM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.64%
CTNM annual free cash flow is higher than 84.64% of companies in Healthcare sector

High & Low

All-time High

$18.93 M
CTNM annual free cash flow is currently at an all-time high

3-Year Low

-$26.43 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CTNM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
CTNM next annual earnings announcement is scheduled for Feb 28, 2025

OtherCTNMcash flowmetrics:

Annual CFO

$19.35 M
CTNM annual cash flow from operations is $19.35 million

Annual CFF

$56.18 M
CTNM annual cash flow from financing activities is $56.18 million

Annual CFI

-$65.57 M
CTNM annual cash flow from investing activities is -$65.57 million

Annual CAPEX

$414.00 K
CTNM annual capital expenditures is $414.00 thousand

Quarterly FCF

-$6.25 M
+$2.37 M+27.47%

September 30, 2024

Summary

Performance

3-Month Change

+27.47%

1-Year Change

+43.24%

3-Year Change

-

5-Year Change

-

CTNM Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.57%
CTNM quarterly free cash flow is higher than 42.57% of companies in Healthcare sector

High & Low

All-time High

$40.64 M
CTNM quarterly free cash flow is currently -115.38% below its historical high of $40.64 million

3-Year Low

-$11.01 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTNM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CTNM next earnings announcement is scheduled for Feb 28, 2025

OtherCTNMcash flowmetrics:

Quarterly CFO

-$6.17 M
CTNM quarterly cash flow from operations is -$6.17 million

Quarterly CFF

$13.00 K
CTNM quarterly cash flow from financing activities is $13.00 thousand

Quarterly CFI

-$30.18 M
CTNM quarterly cash flow from investing activities is -$30.18 million

Quarterly CAPEX

-
CTNM quarterly capital expenditures value is unknown

TTM FCF

-$34.00 M
-$852.00 K-2.57%

September 30, 2024

Summary

Performance

3-Month Change

-2.57%

1-Year Change

-279.58%

3-Year Change

-

5-Year Change

-

CTNM TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.67%
CTNM TTM free cash flow is higher than 37.67% of companies in Healthcare sector

High & Low

All-time High

$35.35 M
CTNM TTM free cash flow is currently -196.20% below its historical high of $35.35 million

3-Year Low

-$34.00 M
CTNM TTM free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTNM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CTNM next earnings announcement is scheduled for Feb 28, 2025

OtherCTNMcash flowmetrics:

TTM CFO

-$33.35 M
CTNM TTM cash flow from operations is -$33.35 million

TTM CFF

$108.04 M
CTNM TTM cash flow from financing activities is $108.04 million

TTM CFI

-$51.32 M
CTNM TTM cash flow from investing activities is -$51.32 million

TTM CAPEX

-
CTNM TTM capital expenditures value is unknown

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

$18.93 M
CTNM annual free cash flow is $18.93 million

Annual CFO

$19.35 M
CTNM annual cash flow from operations is $19.35 million

Annual CAPEX

$414.00 K
CTNM annual capital expenditures is $414.00 thousand

CTNM Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+193.6%+43.2%-279.6%
3 y3 years+171.6%--
5 y5 years+171.6%--

CTNM Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+171.6%-115.4%+43.2%-196.2%at low
5 y5-yearat high+171.6%-115.4%+43.2%-196.2%at low
alltimeall timeat high+171.6%-115.4%+43.2%-196.2%at low

Contineum Therapeutics Class A Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.25 M(-27.5%)
-$34.00 M(+2.6%)
Jun 2024
-
-$8.62 M(+6.1%)
-$33.15 M(-305.8%)
Mar 2024
-
-$8.12 M(-26.3%)
$16.11 M(-14.9%)
Dec 2023
$18.93 M
-$11.01 M(+104.0%)
$18.93 M(-36.8%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$5.40 M(-113.3%)
$29.95 M(-15.3%)
Jun 2023
-
$40.64 M(-867.4%)
$35.35 M(-767.4%)
Mar 2023
-
-$5.30 M
-$5.30 M
Dec 2022
-$20.24 M(-23.4%)
-
-
Dec 2021
-$26.43 M
-
-

FAQ

  • What is Contineum Therapeutics Class A annual free cash flow?
  • What is the all time high annual FCF for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A annual FCF year-on-year change?
  • What is Contineum Therapeutics Class A quarterly free cash flow?
  • What is the all time high quarterly FCF for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A quarterly FCF year-on-year change?
  • What is Contineum Therapeutics Class A TTM free cash flow?
  • What is the all time high TTM FCF for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A TTM FCF year-on-year change?

What is Contineum Therapeutics Class A annual free cash flow?

The current annual FCF of CTNM is $18.93 M

What is the all time high annual FCF for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high annual free cash flow is $18.93 M

What is Contineum Therapeutics Class A annual FCF year-on-year change?

Over the past year, CTNM annual free cash flow has changed by +$39.17 M (+193.56%)

What is Contineum Therapeutics Class A quarterly free cash flow?

The current quarterly FCF of CTNM is -$6.25 M

What is the all time high quarterly FCF for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high quarterly free cash flow is $40.64 M

What is Contineum Therapeutics Class A quarterly FCF year-on-year change?

Over the past year, CTNM quarterly free cash flow has changed by +$4.76 M (+43.24%)

What is Contineum Therapeutics Class A TTM free cash flow?

The current TTM FCF of CTNM is -$34.00 M

What is the all time high TTM FCF for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high TTM free cash flow is $35.35 M

What is Contineum Therapeutics Class A TTM FCF year-on-year change?

Over the past year, CTNM TTM free cash flow has changed by -$52.94 M (-279.58%)